1. Home
  2. IQV vs EXC Comparison

IQV vs EXC Comparison

Compare IQV & EXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • EXC
  • Stock Information
  • Founded
  • IQV 1982
  • EXC 1999
  • Country
  • IQV United States
  • EXC United States
  • Employees
  • IQV N/A
  • EXC N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • EXC Power Generation
  • Sector
  • IQV Health Care
  • EXC Utilities
  • Exchange
  • IQV Nasdaq
  • EXC Nasdaq
  • Market Cap
  • IQV 35.7B
  • EXC 37.0B
  • IPO Year
  • IQV 2013
  • EXC N/A
  • Fundamental
  • Price
  • IQV $200.02
  • EXC $40.54
  • Analyst Decision
  • IQV Strong Buy
  • EXC Buy
  • Analyst Count
  • IQV 17
  • EXC 8
  • Target Price
  • IQV $254.50
  • EXC $43.13
  • AVG Volume (30 Days)
  • IQV 1.4M
  • EXC 6.5M
  • Earning Date
  • IQV 02-06-2025
  • EXC 02-12-2025
  • Dividend Yield
  • IQV N/A
  • EXC 3.74%
  • EPS Growth
  • IQV 27.98
  • EXC 12.91
  • EPS
  • IQV 7.62
  • EXC 2.43
  • Revenue
  • IQV $15,315,000,000.00
  • EXC $22,924,000,000.00
  • Revenue This Year
  • IQV $3.67
  • EXC $1.80
  • Revenue Next Year
  • IQV $4.40
  • EXC $3.40
  • P/E Ratio
  • IQV $26.13
  • EXC $16.69
  • Revenue Growth
  • IQV 3.10
  • EXC 9.03
  • 52 Week Low
  • IQV $187.62
  • EXC $33.35
  • 52 Week High
  • IQV $261.73
  • EXC $41.19
  • Technical
  • Relative Strength Index (RSI)
  • IQV 47.86
  • EXC 62.96
  • Support Level
  • IQV $195.99
  • EXC $39.67
  • Resistance Level
  • IQV $204.10
  • EXC $40.76
  • Average True Range (ATR)
  • IQV 4.78
  • EXC 0.82
  • MACD
  • IQV -0.26
  • EXC 0.12
  • Stochastic Oscillator
  • IQV 40.84
  • EXC 89.49

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About EXC Exelon Corporation

Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C.

Share on Social Networks: